The optical properties of GaBi x As 1-x (0.04 < x < 0.08) grown by molecular beam epitaxy have been studied by photomodulated reflectance spectroscopy. The alloys exhibit a strong reduction in the bandgap as well as an increase in the spin-orbit splitting energy with increasing Bi concentration. These observations are explained by a valence band anticrossing model, which shows that a restructuring of the valence band occurs as the result of an anticrossing interaction between the extended states of the GaAs valence band and the resonant T 2 states of the Bi atoms.
GaBiAs layers have been grown by molecular beam epitaxy at low (270–330°C) temperatures and were characterized by several experimental techniques. It was shown that the spectral photosensitivity cutoff wavelength reaches ∼1.4μm when the growth temperature is as low as 280°C. Optical pump–terahertz probe measurements made on these layers have evidenced that the electron trapping time decreases with decreasing growth temperature from 20 to about 1ps. GaBiAs layers were used for manufacturing photoconductive terahertz emitters and detectors, which, when excited with Ti:sapphire laser pulses, have demonstrated a signal bandwidth of 3THz.
Time-resolved photoluminescence is used to study low-temperature-grown (LTG) GaAs with Be doping. It is observed that the carrier trapping time in the as-grown LTG GaAs increases with Be doping. Similar effect is observed also in the annealed samples doped with less than 3×1019 cm−3 of Be. At higher doping levels, the trapping time in these samples is abruptly reduced to below 100 fs. This behavior is attributed to changes in As antisite density and the compensation effect of Be.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.